Connect Biopharma Holdings (Connect Biopharma Holdings) Current Accrued Expense : $0.65 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Current Accrued Expense?

Connect Biopharma Holdings's Current Accrued Expense for the quarter that ended in Dec. 2023 was $0.65 Mil.

Connect Biopharma Holdings's quarterly Current Accrued Expense declined from Dec. 2022 ($0.82 Mil) to Jun. 2023 ($0.68 Mil) and declined from Jun. 2023 ($0.68 Mil) to Dec. 2023 ($0.65 Mil).

Connect Biopharma Holdings's annual Current Accrued Expense increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.82 Mil) but then declined from Dec. 2022 ($0.82 Mil) to Dec. 2023 ($0.65 Mil).

Connect Biopharma Holdings Current Accrued Expense Historical Data

The historical data trend for Connect Biopharma Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Current Accrued Expense Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

0.08

1.24

0.82

0.65

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial				-	0.69	0.82	0.68	0.65

Connect Biopharma Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Connect Biopharma Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings (Connect Biopharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.